DE eng

Search in the Catalogues and Directories

Page: 1 2
Hits 1 – 20 of 24

1
Protocol for the development of the international population registry for aphasia after stroke (I-PRAISE)
In: Research outputs 2014 to 2021 (2022)
BASE
Show details
2
Protocol for the development of the international population registry for aphasia after stroke (I-PRAISE)
Ali, M.; Ben Basat, A. L.; Berthier, M.. - : Informa UK Limited, 2021
BASE
Show details
3
Utilising a systematic review-based approach to create a database of individual participant data for meta- and network meta-analyses: the RELEASE database of aphasia after stroke
BASE
Show details
4
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis
Leemann, B.; Nilipour, R.; Rose, M. L.. - : Lippincott, Williams & Wilkins, 2021
BASE
Show details
5
Predictors of Poststroke Aphasia Recovery
Bowen, A.; Williams, L.; Pavao Martins, I.. - : Ovid Technologies (Wolters Kluwer Health), 2021
BASE
Show details
6
Communicating simply, but not too simply: Reporting of participants and speech and language interventions for aphasia after stroke
BASE
Show details
7
RELEASE: A protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia
Brady, M. C.; Ali, M.; VandenBerg, K.. - : Taylor & Francis (Routledge), 2019
BASE
Show details
8
Tidier descriptions of speech and language therapy interventions for people with aphasia; consensus from the release collaboration
BASE
Show details
9
Aboriginal mitogenomes reveal 50,000 years of regionalism in Australia
Tobler, R; Rohrlach, A; Soubrier, J. - : Macmillan, 2017
BASE
Show details
10
Creating an international, multidisciplinary, aphasia dataset of individual patient data (IPD) for the REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) project
BASE
Show details
11
A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome ...
Torgerson, Dara G.; Levin, Albert M.; Wilson, James G.. - : The University of North Carolina at Chapel Hill University Libraries, 2016
BASE
Show details
12
A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome
Mathias, Rasika Ann; Taub, Margaret A.; Gignoux, Christopher R.. - : Nature Publishing Group, 2016
BASE
Show details
13
Contextual behavioural coaching: An evidence-based model for supporting behaviour change
In: 11 ; 2 ; 142 ; 154 (2016)
BASE
Show details
14
Studying the family diet: an investigation into association between diet, lifestyle and weight status in Malaysian families
Yang, W. Y.; Burrows, T.; MacDonald-Wicks, L.. - : Nutrition Society of Malaysia, 2015
BASE
Show details
15
A Benign Paroxysmal Positional Vertigo Specialty Clinic: A Model for Va Health Care
In: ETSU Faculty Works (2013)
BASE
Show details
16
Basal insulin and cardiovascular and other outcomes in dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
Abstract: BACKGROUND: The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS: We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a target fasting blood glucose level of ≤95 mg per deciliter [5.3 mmol per liter]) or standard care and to receive n-3 fatty acids or placebo with the use of a 2-by-2 factorial design. The results of the comparison between insulin glargine and standard care are reported here. The coprimary outcomes were nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes and these events plus revascularization or hospitalization for heart failure. Microvascular outcomes, incident diabetes, hypoglycemia, weight, and cancers were also compared between groups. RESULTS: The median follow-up was 6.2 years (interquartile range, 5.8 to 6.7). Rates of incident cardiovascular outcomes were similar in the insulin-glargine and standard-care groups: 2.94 and 2.85 per 100 person-years, respectively, for the first coprimary outcome (hazard ratio, 1.02; 95% confidence interval [CI], 0.94 to 1.11; P=0.63) and 5.52 and 5.28 per 100 person-years, respectively, for the second coprimary outcome (hazard ratio, 1.04; 95% CI, 0.97 to 1.11; P=0.27). New diabetes was diagnosed approximately 3 months after therapy was stopped among 30% versus 35% of 1456 participants without baseline diabetes (odds ratio, 0.80; 95% CI, 0.64 to 1.00; P=0.05). Rates of severe hypoglycemia were 1.00 versus 0.31 per 100 person-years. Median weight increased by 1.6 kg in the insulin-glargine group and fell by 0.5 kg in the standard-care group. There was no significant difference in cancers (hazard ratio, 1.00; 95% CI, 0.88 to 1.13; P=0.97). CONCLUSIONS: When used to target normal fasting plasma glucose levels for more than 6 years, insulin glargine had a neutral effect on cardiovascular outcomes and cancers. Although it reduced new-onset diabetes, insulin glargine also increased hypoglycemia and modestly increased weight. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).
Keyword: Aged; Blood Glucose/analysis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Cholesterol/blood; Combination; Diabetes Mellitus; Double-Blind Method; Drug Therapy; Fasting; Fatty Acids; Female; Follow-Up Studies; Glucose Intolerance/complications; Glucose Intolerance/drug therapy; Hospitalization; Humans; Hypoglycemia/chemically induced; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Incidence; Insulin; Intention to Treat Analysis; Long-Acting/adverse effects; Long-Acting/therapeutic use; Male; Middle Aged; Omega-3/therapeutic use; Proportional Hazards Models; Triglycerides/blood; Type 2/complications; Type 2/drug therapy
URL: https://doi.org/10.1056/NEJMoa1203858
https://serval.unil.ch/notice/serval:BIB_24F963809D9F
BASE
Hide details
17
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
BASE
Show details
18
Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children
BASE
Show details
19
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.
Veitenhansl M, Stegner K; Chatellier G, Group D.E.S.I.R.; DIABHYCAR Study Group, Nichols GA. - : Springer, 2004. : country:DEU, 2004. : place:Berli, 2004
BASE
Show details
20
The child: Service needs, evaluation and intervention - Pre-school assessment project comparing assessment in the clinic or home
In: International journal of language & communication disorders. - Oxford : Wiley-Blackwell 33 (1998), 520-525
OLC Linguistik
Show details

Page: 1 2

Catalogues
0
0
1
0
0
0
0
Bibliographies
1
0
0
0
0
0
0
1
2
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
19
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern